ARENSIA Exploratory Medicine — Kyiv

Public research footprint of ARENSIA Exploratory Medicine, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Ulcerative Colitis · Chronic Lymphocytic Leukemia · Lymphoma, Non-Hodgkin · Diffuse-large B-cell Lymphoma (DLBCL)

Recently updated registry entries

NCT06788756 — L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy… (Recruiting)
NCT06506643 — Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms (Recruiting)
NCT03917381 — GEN1046 Safety Trial in Patients With Malignant Solid Tumors (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ARENSIA Exploratory Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.